Impact of time from diagnosis to chemotherapy in advanced gastric cancer: A Propensity Score Matching Study to Balance Prognostic Factors

Figure 1 Study flow chart. A-GC: Advanced gastric cancer.

Figure 2 Overall survival in patients with advanced gastric cancer. The median overall survival time was 303 d.

Figure 3 Overall survival in advanced gastric cancer patients in the early and elective wait time groups. There was a difference in median survival time between the early and elective wait time groups (230 d vs 340 d, respectively, log-rank test P = 0.0537, Wilcoxon test P = 0.0188). WT: Wait time.

Figure 4 Overall survival of propensity-matched patients with advanced gastric cancer in the early and elective wait time groups. There was no significant difference in median survival time between the early and elective wait time groups (303 d vs 311 d, respectively, log-rank P = 0.9832). WT: Wait time.